PATAS - AdipoPharma
Alternative Names: PATAS trifluoroacetate; Peptide derived from PKC alpha Targeting AlmS - AdipoPharma; Peptide-mimic of PKC Alpha Targeting ALMS - AdipoPharmaLatest Information Update: 06 Nov 2025
At a glance
- Originator INSERM; Monash University; University of Birmingham; University of Strasbourg
- Class Antihyperglycaemics; Peptides
- Mechanism of Action Adipocyte modulators
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Type 2 diabetes mellitus